FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019224077> ?p ?o ?g. }

• W2019224077 endingPage "997" @default.
• W2019224077 startingPage "997" @default.
• W2019224077 abstract "There is a paucity of controlled treatment trials for the treatment of conversion disorder, seizures type, also known as psychogenic nonepileptic seizures (PNES). Psychogenic nonepileptic seizures, the most common conversion disorder, are as disabling as epilepsy and are not adequately addressed or treated by mental health clinicians.To evaluate different PNES treatments compared with standard medical care (treatment as usual).Pilot randomized clinical trial at 3 academic medical centers with mental health clinicians trained to administer psychotherapy or psychopharmacology to outpatients with PNES. Thirty-eight participants were randomized in a blocked schedule among 3 sites to 1 of 4 treatment arms and were followed up for 16 weeks between September 2008 and February 2012; 34 were included in the analysis.Medication (flexible-dose sertraline hydrochloride) only, cognitive behavioral therapy informed psychotherapy (CBT-ip) only, CBT-ip with medication (sertraline), or treatment as usual.Seizure frequency was the primary outcome; psychosocial and functioning measures, including psychiatric symptoms, social interactions, quality of life, and global functioning, were secondary outcomes. Data were collected prospectively, weekly, and with baseline, week 2, midpoint (week 8), and exit (week 16) batteries. Within-group analyses for each arm were performed on primary (seizure frequency) and secondary outcomes from treatment-blinded raters using an intention-to-treat analysis.The psychotherapy (CBT-ip) arm showed a 51.4% seizure reduction (P = .01) and significant improvement from baseline in secondary measures including depression, anxiety, quality of life, and global functioning (P < .001). The combined arm (CBT-ip with sertraline) showed 59.3% seizure reduction (P = .008) and significant improvements in some secondary measures, including global functioning (P = .007). The sertraline-only arm did not show a reduction in seizures (P = .08). The treatment as usual group showed no significant seizure reduction or improvement in secondary outcome measures (P = .19).This pilot randomized clinical trial for PNES revealed significant seizure reduction and improved comorbid symptoms and global functioning with CBT-ip for PNES without and with sertraline. There were no improvements in the sertraline-only or treatment-as-usual arms. This study supports the use of manualized psychotherapy for PNES and successful training of mental health clinicians in the treatment. Future studies could assess larger-scale intervention dissemination.clinicaltrials.gov Identifier: NCT00835627." @default.
• W2019224077 created "2016-06-24" @default.
• W2019224077 creator A5011156025 @default.
• W2019224077 creator A5016604628 @default.
• W2019224077 creator A5020477697 @default.
• W2019224077 creator A5020909854 @default.
• W2019224077 creator A5022266535 @default.
• W2019224077 creator A5030070412 @default.
• W2019224077 creator A5054845174 @default.
• W2019224077 creator A5075100657 @default.
• W2019224077 creator A5088228787 @default.
• W2019224077 date "2014-09-01" @default.
• W2019224077 modified "2023-10-11" @default.
• W2019224077 title "Multicenter Pilot Treatment Trial for Psychogenic Nonepileptic Seizures" @default.
• W2019224077 cites W1592133390 @default.
• W2019224077 cites W1963707830 @default.
• W2019224077 cites W1969055995 @default.
• W2019224077 cites W1970226532 @default.
• W2019224077 cites W1972632615 @default.
• W2019224077 cites W1989180255 @default.
• W2019224077 cites W2005697217 @default.
• W2019224077 cites W2017422058 @default.
• W2019224077 cites W2017542116 @default.
• W2019224077 cites W2022458589 @default.
• W2019224077 cites W2027105183 @default.
• W2019224077 cites W2035123334 @default.
• W2019224077 cites W2038868018 @default.
• W2019224077 cites W2038928291 @default.
• W2019224077 cites W2052059818 @default.
• W2019224077 cites W2052838706 @default.
• W2019224077 cites W2065657467 @default.
• W2019224077 cites W2066626305 @default.
• W2019224077 cites W2067347131 @default.
• W2019224077 cites W2069825985 @default.
• W2019224077 cites W2080238932 @default.
• W2019224077 cites W2089508038 @default.
• W2019224077 cites W2091535760 @default.
• W2019224077 cites W2094032896 @default.
• W2019224077 cites W2111290864 @default.
• W2019224077 cites W2116722753 @default.
• W2019224077 cites W2121555092 @default.
• W2019224077 cites W2122843283 @default.
• W2019224077 cites W2124518166 @default.
• W2019224077 cites W2125084350 @default.
• W2019224077 cites W2125696454 @default.
• W2019224077 cites W2127697771 @default.
• W2019224077 cites W2141424489 @default.
• W2019224077 cites W2152690559 @default.
• W2019224077 cites W2153302107 @default.
• W2019224077 cites W2154776804 @default.
• W2019224077 cites W2155000941 @default.
• W2019224077 cites W2161550589 @default.
• W2019224077 cites W2170302766 @default.
• W2019224077 cites W2254051562 @default.
• W2019224077 cites W2326556724 @default.
• W2019224077 cites W1985147557 @default.
• W2019224077 cites W2083637730 @default.
• W2019224077 doi "https://doi.org/10.1001/jamapsychiatry.2014.817" @default.
• W2019224077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24989152" @default.
• W2019224077 hasPublicationYear "2014" @default.
• W2019224077 type Work @default.
• W2019224077 sameAs 2019224077 @default.
• W2019224077 citedByCount "318" @default.
• W2019224077 countsByYear W20192240772014 @default.
• W2019224077 countsByYear W20192240772015 @default.
• W2019224077 countsByYear W20192240772016 @default.
• W2019224077 countsByYear W20192240772017 @default.
• W2019224077 countsByYear W20192240772018 @default.
• W2019224077 countsByYear W20192240772019 @default.
• W2019224077 countsByYear W20192240772020 @default.
• W2019224077 countsByYear W20192240772021 @default.
• W2019224077 countsByYear W20192240772022 @default.
• W2019224077 countsByYear W20192240772023 @default.
• W2019224077 crossrefType "journal-article" @default.
• W2019224077 hasAuthorship W2019224077A5011156025 @default.
• W2019224077 hasAuthorship W2019224077A5016604628 @default.
• W2019224077 hasAuthorship W2019224077A5020477697 @default.
• W2019224077 hasAuthorship W2019224077A5020909854 @default.
• W2019224077 hasAuthorship W2019224077A5022266535 @default.
• W2019224077 hasAuthorship W2019224077A5030070412 @default.
• W2019224077 hasAuthorship W2019224077A5054845174 @default.
• W2019224077 hasAuthorship W2019224077A5075100657 @default.
• W2019224077 hasAuthorship W2019224077A5088228787 @default.
• W2019224077 hasConcept C118552586 @default.
• W2019224077 hasConcept C126322002 @default.
• W2019224077 hasConcept C150966472 @default.
• W2019224077 hasConcept C159110408 @default.
• W2019224077 hasConcept C160146798 @default.
• W2019224077 hasConcept C168563851 @default.
• W2019224077 hasConcept C2777669559 @default.
• W2019224077 hasConcept C2778186239 @default.
• W2019224077 hasConcept C2779177272 @default.
• W2019224077 hasConcept C2779951463 @default.
• W2019224077 hasConcept C2781265626 @default.
• W2019224077 hasConcept C558461103 @default.
• W2019224077 hasConcept C71924100 @default.
• W2019224077 hasConceptScore W2019224077C118552586 @default.
• W2019224077 hasConceptScore W2019224077C126322002 @default.

• next